Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qinghao Pollen Drops for Allergic Rhinitis
CTR20161038Phase 3Completed
- Sponsor
- Wolwo Biotech
- Start
- Jan 2017
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of artemisia annua allergen extract in allergic rhinitis (AR), sponsored by Wolwo Biotech. Started Jan 2017; status: completed.
02
Drugs
artemisia annua allergen extract
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on CTR20161038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20161038.